A blood test done in early pregnancy that measures cell-free DNA methylation could represent a novel way to predict the risk of preterm pre-eclampsia.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chappell, L. C., Cluver, C. A., Kingdom, J. & Tong, S. Pre-eclampsia. Lancet 398, 341–354 (2021).
Duley, L., Meher, S., Hunter, K. E., Seidler, A. L. & Askie, L. M. Cochrane Database Syst. Rev. 2019, CD004659 (2019).
Hoffman, M. K. et al. Lancet 395, 285–293 (2020).
Rolnik, D. L. et al. N. Engl. J. Med. 377, 613–622 (2017).
von Dadelszen, P., Syngelaki, A., Akolekar, R., Magee, L. A. & Nicolaides, K. H. BJOG 130, 524–530 (2023).
De Borre, M. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02510-5 (2023).
Greenberg, M. V. C. & Bourc'his, D. Nat. Rev. Mol. Cell Biol. 20, 590–607 (2019).
MacDonald, T. M., Walker, S. P., Hannan, N. J., Tong, S. & Kaitu'u-Lino, T. J. EBioMedicine 75, 103780 (2022).
Hastie, R. et al. Am. J. Obstet. Gynecol. 224, 95.e1–95.e12 (2021).
Chaemsaithong, P., Sahota, D. S. & Poon, L. C. Am. J. Obstet. Gynecol. 226, S1071–S1097.e1072 (2022).
Honigberg, M. C. et al. Nat. Med. 29, 1540–1549 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Kaitu’u-Lino, T.J., Bartho, L.A. & Tong, S. Using the methylome to predict pre-eclampsia. Nat Med 29, 2177–2178 (2023). https://doi.org/10.1038/s41591-023-02499-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02499-x